Literature DB >> 29796876

De novo FBXO11 mutations are associated with intellectual disability and behavioural anomalies.

Daniel Fritzen1, Alma Kuechler2, Mona Grimmel3, Jessica Becker1, Sophia Peters1, Marc Sturm3, Hela Hundertmark1, Axel Schmidt1, Martina Kreiß1, Tim M Strom4,5, Dagmar Wieczorek2,6, Tobias B Haack3,5, Stefanie Beck-Wödl3, Kirsten Cremer1, Hartmut Engels7.   

Abstract

Intellectual disability (ID) has an estimated prevalence of 1.5-2%. In most affected individuals, its genetic basis remains unclear. Whole exome sequencing (WES) studies have identified a multitude of novel causative gene defects and have shown that a large proportion of sporadic ID cases results from de novo mutations. Here, we present two unrelated individuals with similar clinical features and deleterious de novo variants in FBXO11 detected by WES. Individual 1, a 14-year-old boy, has mild ID as well as mild microcephaly, corrected cleft lip and alveolus, hyperkinetic disorder, mild brain atrophy and minor facial dysmorphism. WES detected a heterozygous de novo 1 bp insertion in the splice donor site of exon 3. Individual 2, a 3-year-old boy, showed ID and pre- and postnatal growth retardation, postnatal mild microcephaly, hyperkinetic and restless behaviour, as well as mild dysmorphism. WES detected a heterozygous de novo frameshift mutation. While ten individuals with ID and de novo variants in FBXO11 have been reported as part of larger studies, only one of the reports has some additional clinical data. Interestingly, the latter individual carries the identical mutation as our individual 2 and also displays ID, intrauterine growth retardation, microcephaly, behavioural anomalies, and dysmorphisms. Thus, we confirm deleterious de novo mutations in FBXO11 as a cause of ID and start the delineation of the associated clinical picture which may also comprise postnatal microcephaly or borderline small head size and behavioural anomalies.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29796876     DOI: 10.1007/s00439-018-1892-1

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  43 in total

Review 1.  The epidemiology of mental retardation: challenges and opportunities in the new millennium.

Authors:  Helen Leonard; Xingyan Wen
Journal:  Ment Retard Dev Disabil Res Rev       Date:  2002

2.  FBXO11 inactivation leads to abnormal germinal-center formation and lymphoproliferative disease.

Authors:  Christof Schneider; Ning Kon; Letizia Amadori; Qiong Shen; Friederike H Schwartz; Benjamin Tischler; Marion Bossennec; David Dominguez-Sola; Govind Bhagat; Wei Gu; Katia Basso; Riccardo Dalla-Favera
Journal:  Blood       Date:  2016-05-10       Impact factor: 22.113

3.  De novo mutations revealed by whole-exome sequencing are strongly associated with autism.

Authors:  Stephan J Sanders; Michael T Murtha; Abha R Gupta; John D Murdoch; Melanie J Raubeson; A Jeremy Willsey; A Gulhan Ercan-Sencicek; Nicholas M DiLullo; Neelroop N Parikshak; Jason L Stein; Michael F Walker; Gordon T Ober; Nicole A Teran; Youeun Song; Paul El-Fishawy; Ryan C Murtha; Murim Choi; John D Overton; Robert D Bjornson; Nicholas J Carriero; Kyle A Meyer; Kaya Bilguvar; Shrikant M Mane; Nenad Sestan; Richard P Lifton; Murat Günel; Kathryn Roeder; Daniel H Geschwind; Bernie Devlin; Matthew W State
Journal:  Nature       Date:  2012-04-04       Impact factor: 49.962

4.  Inactivating mutations of acetyltransferase genes in B-cell lymphoma.

Authors:  Laura Pasqualucci; David Dominguez-Sola; Annalisa Chiarenza; Giulia Fabbri; Adina Grunn; Vladimir Trifonov; Lawryn H Kasper; Stephanie Lerach; Hongyan Tang; Jing Ma; Davide Rossi; Amy Chadburn; Vundavalli V Murty; Charles G Mullighan; Gianluca Gaidano; Raul Rabadan; Paul K Brindle; Riccardo Dalla-Favera
Journal:  Nature       Date:  2011-03-10       Impact factor: 49.962

5.  I-TASSER server: new development for protein structure and function predictions.

Authors:  Jianyi Yang; Yang Zhang
Journal:  Nucleic Acids Res       Date:  2015-04-16       Impact factor: 16.971

6.  Benign and malignant tumors in Rubinstein-Taybi syndrome.

Authors:  Max V Boot; Martine J van Belzen; Lucy I Overbeek; Nathalie Hijmering; Matias Mendeville; Quinten Waisfisz; Pieter Wesseling; Raoul C Hennekam; Daphne de Jong
Journal:  Am J Med Genet A       Date:  2018-01-23       Impact factor: 2.802

7.  Prevalence and architecture of de novo mutations in developmental disorders.

Authors: 
Journal:  Nature       Date:  2017-01-25       Impact factor: 49.962

8.  Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results.

Authors:  Sharon E Plon; Diana M Eccles; Douglas Easton; William D Foulkes; Maurizio Genuardi; Marc S Greenblatt; Frans B L Hogervorst; Nicoline Hoogerbrugge; Amanda B Spurdle; Sean V Tavtigian
Journal:  Hum Mutat       Date:  2008-11       Impact factor: 4.878

9.  Systematic Phenomics Analysis Deconvolutes Genes Mutated in Intellectual Disability into Biologically Coherent Modules.

Authors:  Korinna Kochinke; Christiane Zweier; Bonnie Nijhof; Michaela Fenckova; Pavel Cizek; Frank Honti; Shivakumar Keerthikumar; Merel A W Oortveld; Tjitske Kleefstra; Jamie M Kramer; Caleb Webber; Martijn A Huynen; Annette Schenck
Journal:  Am J Hum Genet       Date:  2016-01-07       Impact factor: 11.025

10.  A mouse-to-man candidate gene study identifies association of chronic otitis media with the loci TGIF1 and FBXO11.

Authors:  Mahmood F Bhutta; Jane Lambie; Lindsey Hobson; Anuj Goel; Lena Hafrén; Elisabet Einarsdottir; Petri S Mattila; Martin Farrall; Steve Brown; Martin J Burton
Journal:  Sci Rep       Date:  2017-10-02       Impact factor: 4.379

View more
  15 in total

1.  Novel HIVEP2 Variants in Patients with Intellectual Disability.

Authors:  Joohyun Park; Roberto Colombo; Karin Schäferhoff; Luigi Janiri; Mona Grimmel; Marc Sturm; Ute Grasshoff; Andreas Dufke; Tobias B Haack; Martin Kehrer
Journal:  Mol Syndromol       Date:  2019-04-03

2.  Bi-allelic HPDL Variants Cause a Neurodegenerative Disease Ranging from Neonatal Encephalopathy to Adolescent-Onset Spastic Paraplegia.

Authors:  Ralf A Husain; Mona Grimmel; Matias Wagner; J Christopher Hennings; Christian Marx; René G Feichtinger; Abdelkrim Saadi; Kevin Rostásy; Florentine Radelfahr; Andrea Bevot; Marion Döbler-Neumann; Hans Hartmann; Laurence Colleaux; Isabell Cordts; Xenia Kobeleva; Hossein Darvish; Somayeh Bakhtiari; Michael C Kruer; Arnaud Besse; Andy Cheuk-Him Ng; Diana Chiang; Francois Bolduc; Abbas Tafakhori; Shrikant Mane; Saghar Ghasemi Firouzabadi; Antje K Huebner; Rebecca Buchert; Stefanie Beck-Woedl; Amelie J Müller; Lucia Laugwitz; Thomas Nägele; Zhao-Qi Wang; Tim M Strom; Marc Sturm; Thomas Meitinger; Thomas Klockgether; Olaf Riess; Thomas Klopstock; Ulrich Brandl; Christian A Hübner; Marcus Deschauer; Johannes A Mayr; Penelope E Bonnen; Ingeborg Krägeloh-Mann; Saskia B Wortmann; Tobias B Haack
Journal:  Am J Hum Genet       Date:  2020-07-23       Impact factor: 11.025

3.  Frequent mutations of FBXO11 highlight BCL6 as a therapeutic target in Burkitt lymphoma.

Authors:  Chiara Pighi; Taek-Chin Cheong; Mara Compagno; Enrico Patrucco; Maddalena Arigoni; Martina Olivero; Qi Wang; Cristina López; Stephan H Bernhart; Bruno M Grande; Teresa Poggio; Fernanda Langellotto; Lisa Bonello; Riccardo Dall'Olio; Sandra Martínez-Martín; Luca Molinaro; Paola Francia di Celle; Jonathan R Whitfield; Laura Soucek; Claudia Voena; Raffaele A Calogero; Ryan D Morin; Louis M Staudt; Reiner Siebert; Alberto Zamò; Roberto Chiarle
Journal:  Blood Adv       Date:  2021-12-14

4.  Germline variants in tumor suppressor FBXW7 lead to impaired ubiquitination and a neurodevelopmental syndrome.

Authors:  Sarah E M Stephenson; Gregory Costain; Laura E R Blok; Michael A Silk; Thanh Binh Nguyen; Xiaomin Dong; Dana E Alhuzaimi; James J Dowling; Susan Walker; Kimberly Amburgey; Robin Z Hayeems; Lance H Rodan; Marc A Schwartz; Jonathan Picker; Sally A Lynch; Aditi Gupta; Kristen J Rasmussen; Lisa A Schimmenti; Eric W Klee; Zhiyv Niu; Katherine E Agre; Ilana Chilton; Wendy K Chung; Anya Revah-Politi; P Y Billie Au; Christopher Griffith; Melissa Racobaldo; Annick Raas-Rothschild; Bruria Ben Zeev; Ortal Barel; Sebastien Moutton; Fanny Morice-Picard; Virginie Carmignac; Jenny Cornaton; Nathalie Marle; Orrin Devinsky; Chandler Stimach; Stephanie Burns Wechsler; Bryan E Hainline; Katie Sapp; Marjolaine Willems; Ange-Line Bruel; Kerith-Rae Dias; Carey-Anne Evans; Tony Roscioli; Rani Sachdev; Suzanna E L Temple; Ying Zhu; Joshua J Baker; Ingrid E Scheffer; Fiona J Gardiner; Amy L Schneider; Alison M Muir; Heather C Mefford; Amy Crunk; Elizabeth M Heise; Francisca Millan; Kristin G Monaghan; Richard Person; Lindsay Rhodes; Sarah Richards; Ingrid M Wentzensen; Benjamin Cogné; Bertrand Isidor; Mathilde Nizon; Marie Vincent; Thomas Besnard; Amelie Piton; Carlo Marcelis; Kohji Kato; Norihisa Koyama; Tomoo Ogi; Elaine Suk-Ying Goh; Christopher Richmond; David J Amor; Jessica O Boyce; Angela T Morgan; Michael S Hildebrand; Antony Kaspi; Melanie Bahlo; Rún Friðriksdóttir; Hildigunnur Katrínardóttir; Patrick Sulem; Kári Stefánsson; Hans Tómas Björnsson; Simone Mandelstam; Manuela Morleo; Milena Mariani; Marcello Scala; Andrea Accogli; Annalaura Torella; Valeria Capra; Mathew Wallis; Sandra Jansen; Quinten Weisfisz; Hugoline de Haan; Simon Sadedin; Sze Chern Lim; Susan M White; David B Ascher; Annette Schenck; Paul J Lockhart; John Christodoulou; Tiong Yang Tan
Journal:  Am J Hum Genet       Date:  2022-04-07       Impact factor: 11.043

5.  A Genocentric Approach to Discovery of Mendelian Disorders.

Authors:  Adam W Hansen; Mullai Murugan; He Li; Michael M Khayat; Liwen Wang; Jill Rosenfeld; B Kim Andrews; Shalini N Jhangiani; Zeynep H Coban Akdemir; Fritz J Sedlazeck; Allison E Ashley-Koch; Pengfei Liu; Donna M Muzny; Erica E Davis; Nicholas Katsanis; Aniko Sabo; Jennifer E Posey; Yaping Yang; Michael F Wangler; Christine M Eng; V Reid Sutton; James R Lupski; Eric Boerwinkle; Richard A Gibbs
Journal:  Am J Hum Genet       Date:  2019-10-24       Impact factor: 11.025

6.  Breakpoint Mapping of Symptomatic Balanced Translocations Links the EPHA6, KLF13 and UBR3 Genes to Novel Disease Phenotype.

Authors:  Victor Murcia Pienkowski; Marzena Kucharczyk; Małgorzata Rydzanicz; Barbara Poszewiecka; Katarzyna Pachota; Marlena Młynek; Piotr Stawiński; Agnieszka Pollak; Joanna Kosińska; Katarzyna Wojciechowska; Monika Lejman; Agata Cieślikowska; Dorota Wicher; Agnieszka Stembalska; Karolina Matuszewska; Anna Materna-Kiryluk; Anna Gambin; Krystyna Chrzanowska; Małgorzata Krajewska-Walasek; Rafał Płoski
Journal:  J Clin Med       Date:  2020-04-25       Impact factor: 4.241

7.  KCNC1-related disorders: new de novo variants expand the phenotypic spectrum.

Authors:  Joohyun Park; Mahmoud Koko; Ulrike B S Hedrich; Andreas Hermann; Kirsten Cremer; Edda Haberlandt; Mona Grimmel; Bader Alhaddad; Stefanie Beck-Woedl; Merle Harrer; Daniela Karall; Lisa Kingelhoefer; Andreas Tzschach; Lars C Matthies; Tim M Strom; Erich Bernd Ringelstein; Marc Sturm; Hartmut Engels; Markus Wolff; Holger Lerche; Tobias B Haack
Journal:  Ann Clin Transl Neurol       Date:  2019-06-07       Impact factor: 4.511

8.  De Novo Missense Variants in FBXW11 Cause Diverse Developmental Phenotypes Including Brain, Eye, and Digit Anomalies.

Authors:  Richard J Holt; Rodrigo M Young; Berta Crespo; Fabiola Ceroni; Cynthia J Curry; Emanuele Bellacchio; Dorine A Bax; Andrea Ciolfi; Marleen Simon; Christina R Fagerberg; Ellen van Binsbergen; Alessandro De Luca; Luigi Memo; William B Dobyns; Alaa Afif Mohammed; Samuel J H Clokie; Celia Zazo Seco; Yong-Hui Jiang; Kristina P Sørensen; Helle Andersen; Jennifer Sullivan; Zöe Powis; Anna Chassevent; Constance Smith-Hicks; Slavé Petrovski; Thalia Antoniadi; Vandana Shashi; Bruce D Gelb; Stephen W Wilson; Dianne Gerrelli; Marco Tartaglia; Nicolas Chassaing; Patrick Calvas; Nicola K Ragge
Journal:  Am J Hum Genet       Date:  2019-08-08       Impact factor: 11.025

Review 9.  Essential genetic findings in neurodevelopmental disorders.

Authors:  Ana R Cardoso; Mónica Lopes-Marques; Raquel M Silva; Catarina Serrano; António Amorim; Maria J Prata; Luísa Azevedo
Journal:  Hum Genomics       Date:  2019-07-09       Impact factor: 4.639

10.  Zonisamide-responsive myoclonus in SEMA6B-associated progressive myoclonic epilepsy.

Authors:  Rebecca Herzog; Yorck Hellenbroich; Norbert Brüggemann; Katja Lohmann; Mona Grimmel; Tobias B Haack; Sarah von Spiczak; Alexander Münchau
Journal:  Ann Clin Transl Neurol       Date:  2021-06-06       Impact factor: 4.511

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.